← Evidence map

ArticleMicroorganisms2024

Immunological and Safety Considerations When Selecting the Dose Formulation of a Purified Inactivated Zika Virus Vaccine (PIZV).

Camilo J Acosta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39065260